Sernova Corp. is a clinical-stage regenerative medicine company commercializing products which benefit patients with chronic metabolic, neurological and hematological diseases with first therapeutic applications in diabetes and hemophilia. The company is currently conducting a PI/II trial in diabetic patients with Hypoglycemia unawareness.
Healthcare/Medical Diagnostics & Research
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by